January 16, 2025
Trending Now
1
New Obesity Definitions Introduced by Global Commission
2
Trial: High-Dose Semaglutide Cuts Weight 20.7%
3
Medical Editors Sound Alarm on Fake Journals
4
Comparative Analysis Ranks Mediterranean Diet for Prediabetes
5
FDA Chief Warns of Online Drug Risks
6
GLP-1 Drugs Linked to Fewer Surgery Risks
Conference Coverage
2024 SABCS
American Academy of Ophthalmology annual meeting
January 01, 2025
An Imaging-related Clinical Trial Endpoint
September 01, 2024
An Update on SLT Clinical Trials
October 01, 2024
Fellow Eye Dosing of Gene Therapy Found Safe, Effective
ESMO Congress 2023
November 01, 2023
Advanced RET-Mutant Medullary Thyroid Cancer: First-Line Selpercatinib
Clinical Guidelines
View MoreJanuary 16, 2025
New XLH Guidelines Shift Primary Therapy to Burosumab
January 14, 2025
Does Screening Cut Hip Fracture Risks?
January 02, 2025
New ADA guide covers CDT codes for saliva tests
Commentary & Perspectives
View MoreJanuary 06, 2025
Mocktail Trend Surges Among Younger Americans
November 22, 2024
FDA Official Expects Tightened Vaccine Review
June 13, 2024
Role of Embryo Freezing in IVF: An Explainer
June 12, 2024
Religious Group Condemns IVF Procedures
FDA & Government News
View MoreJanuary 17, 2025
FDA Chief Warns of Online Drug Risks
January 17, 2025
Trial: High-Dose Semaglutide Cuts Weight 20.7%
January 16, 2025
FDA Clears Phase 2 Trial: Lorundrostat for OSA-Hypertension
January 15, 2025